AGIOS PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Agios Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2013 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 25, 2024 was 57M shares, a 2.04% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 57M +1.14M +2.04% Oct 25, 2024 10-Q 2024-10-31
Q2 2024 56.9M +1.15M +2.07% Jul 26, 2024 10-Q 2024-08-01
Q1 2024 56.8M +1.19M +2.15% Apr 26, 2024 10-Q 2024-05-02
Q4 2023 56.2M Feb 9, 2024 10-K 2024-02-15
Q3 2023 55.9M +946K +1.72% Oct 27, 2023 10-Q 2023-11-02
Q2 2023 55.7M +921K +1.68% Jul 28, 2023 10-Q 2023-08-03
Q1 2023 55.6M +792K +1.45% Apr 28, 2023 10-Q 2023-05-04
Q3 2022 54.9M +636K +1.17% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 54.8M -4.13M -7.01% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 54.8M -6.79M -11% Apr 29, 2022 10-Q 2022-05-05
Q3 2021 54.3M -15M -21.6% Oct 29, 2021 10-Q 2021-11-03
Q2 2021 59M -10.2M -14.7% Jul 23, 2021 10-Q 2021-07-29
Q1 2021 61.6M -7.32M -10.6% Apr 23, 2021 10-Q/A 2021-05-07
Q3 2020 69.3M +10.4M +17.6% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 69.1M +10.4M +17.6% Jul 24, 2020 10-Q 2020-07-30
Q1 2020 68.9M +10.2M +17.3% Apr 24, 2020 10-Q 2020-04-30
Q4 2019 68.5M +10.1M +17.3% Feb 13, 2020 10-K 2020-02-19
Q3 2019 58.9M +704K +1.21% Oct 25, 2019 10-Q 2019-10-31
Q2 2019 58.8M +760K +1.31% Jul 26, 2019 10-Q 2019-08-01
Q1 2019 58.7M +1.11M +1.92% Apr 26, 2019 10-Q 2019-05-02
Q4 2018 58.4M +1.07M +1.86% Feb 8, 2019 10-K 2019-02-14
Q3 2018 58.2M +9.42M +19.3% Oct 29, 2018 10-Q 2018-11-01
Q2 2018 58M +9.6M +19.8% Jul 30, 2018 10-Q 2018-08-02
Q1 2018 57.6M +9.4M +19.5% Apr 30, 2018 10-Q 2018-05-04
Q4 2017 57.3M +15.1M +35.7% Feb 9, 2018 10-K 2018-02-14
Q3 2017 48.8M +6.74M +16% Oct 30, 2017 10-Q 2017-11-01
Q2 2017 48.4M +10.3M +27.2% Aug 4, 2017 10-Q 2017-08-08
Q1 2017 48.2M +10.3M +27.1% May 1, 2017 10-Q 2017-05-04
Q4 2016 42.2M Feb 14, 2017 10-K 2017-02-16
Q3 2016 42M +4.37M +11.6% Oct 31, 2016 10-Q 2016-11-03
Q2 2016 38M +603K +1.61% Aug 5, 2016 10-Q 2016-08-08
Q1 2016 37.9M +624K +1.67% May 5, 2016 10-Q 2016-05-09
Q3 2015 37.6M +2.96M +8.53% Nov 4, 2015 10-Q 2015-11-06
Q2 2015 37.4M +2.99M +8.67% Aug 5, 2015 10-Q 2015-08-07
Q1 2015 37.3M +5.71M +18.1% May 8, 2015 10-Q 2015-05-11
Q3 2014 34.7M +3.61M +11.6% Nov 6, 2014 10-Q 2014-11-07
Q2 2014 34.5M Aug 6, 2014 10-Q 2014-08-07
Q1 2014 31.6M Mar 14, 2014 10-K 2014-03-18
Q3 2013 31.1M Sep 1, 2013 10-Q 2013-09-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.